Monday - March 23, 2026

Category Archives: Marketing & Sales

Alcohol Use Disorder Pipeline Report 2026 Highlights 30+ Companies and 30+ Therapies Shaping Future Treatment Trends, analyses DelveInsight

Alcohol Use Disorder Pipeline Alcohol Use Disorder companies include Pear Therapeutics, Cybin, Lohocla Research, BioXcel Therapeutics, Pop Test Oncology, Dicerna Pharmaceuticals, Astellas Pharma, Kinnov Therapeutics, MediciNova, Adial Pharmaceuticals, and others According to DelveInsight’s evaluation, the global Alcohol Use Disorder (AUD) … Continue reading →

Hepatocellular Carcinoma Drug Development Landscape Gains Momentum with Over 90 Companies Advancing Innovative Therapies | DelveInsight

Hepatocellular Carcinoma Pipeline Leading Hepatocellular Carcinoma companies involved in this space include Can-Fite BioPharma, Surface Oncology, Novartis Oncology, GlaxoSmithKline, CStone Pharmaceuticals, Chugai Pharmaceutical, and several others. DelveInsight’s latest report, “Hepatocellular Carcinoma Pipeline Insight 2026,” offers an extensive evaluation of the … Continue reading →

Esophageal Cancer Clinical Trial Landscape Gains Momentum as 80+ Biopharma Players Advance Next-Generation Therapies | DelveInsight

Esophageal Cancer Clinical Trials Esophageal Cancer Companies include OncoTherapy Science/Shionogi & Co., Oncolys BioPharma, Lyvgen Biopharma, Adlai Nortye Biopharma, NovaRock Biotherapeutics, Genmab, Genentech, Jiangsu Hengrui Medicine, Taiho Pharmaceutical, Mirati Therapeutics, Boehringer Ingelheim, and several others. DelveInsight’s latest report, “Esophageal Cancer … Continue reading →

Hemophilia Clinical Development Landscape Strengthens as 80+ Companies Drive Innovation | DelveInsight

Hemophilia Pipeline Prominent Hemophilia companies include Centessa Pharmaceuticals, Alnylam Pharmaceuticals, ASC Therapeutics, Spark Therapeutics, Freeline Therapeutics, BioMarin Pharmaceutical, Staidson Beijing BioPharmaceuticals, Pfizer, Sangamo Therapeutics, Amunix, Bioverativ, Novo Nordisk, and others.   DelveInsight’s latest report, “Hemophilia Pipeline Insight, 2026” offers a … Continue reading →

Head and Neck Cancer Clinical Pipeline Accelerates: Over 80 Companies Advancing 100+ Innovative Therapies | DelveInsight

Head and Neck Cancer Pipeline Major Head and Neck Cancer companies driving innovation include Merus, Bicara Therapeutics, Kura Oncology, Theriva Biologics, Nykode Therapeutics, Cue Biopharma, BioNTech, Exelixis, AstraZeneca, Johnson & Johnson, AbbVie, Iovance Biotherapeutics, Immutep, Pyxis Oncology, ALX Oncology, iTeos … Continue reading →

Muscle Invasive Bladder Cancer Market Set for Strong Growth Through 2034, Driven by Expanding Pipeline and Innovation | DelveInsight

Muscle Invasive Bladder Cancer Market The Muscle Invasive Bladder Cancer (MIBC) treatment landscape is undergoing rapid transformation, fueled by an expanding pipeline and active participation from leading pharmaceutical and biotechnology companies such as CG Oncology, Pfizer, UroGen Pharma, Janssen Research … Continue reading →

HER2-Negative Breast Cancer Clinical Pipeline Witnesses Significant Growth as 70+ Companies Accelerate Therapeutic Innovation | DelveInsight

HER2-Negative Breast Cancer Clinical Trials HER2-Negative Breast Cancer companies include Genentech, CytomX Therapeutics, H3 Biomedicine, Regor Therapeutics, Immutep Limited, Merck & Co., Klus Pharma, Olema Pharmaceuticals, BeiGene, AstraZeneca, Janssen/Merck/GSK, Ono Pharmaceutical, Laekna Therapeutics, NanoMab, InSilico Medicine, TYK Medicine, Shanghai Pharmaceutical … Continue reading →

Hepatic Tumor Clinical Trial Landscape Strengthens as 75+ Companies Accelerate Innovation in Emerging Therapies | DelveInsight

Hepatic Tumor Pipeline Hepatic Tumor companies include Can Fite Biopharma, MiNA Therapeutics, Medivir AB, Janssen Research & Development, LLC, Etnova Therapeutics Corp., SillaJen Biotherapeutics, Akeso Biopharma, Shanghai Junshi Biosciences, Genmab/Janssen Biotech, Bio-Thera Solutions, Ocuphire Pharma, Surface Oncology, Genoscience, Onyx Pharmaceuticals, … Continue reading →

Esophageal Cancer Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Eli Lilly, Amgen, Zymeworks, BeiGene

Esophageal Cancer Market Insights, Epidemiology and Market Forecast 2034 The Key Esophageal Cancer Companies in the market include – Eli Lilly and Company, Amgen, Zymeworks, Jazz Pharmaceuticals, Bayer, BeiGene, Innovent Biologics, Apexigen, and others. The Esophageal Cancer market is expected … Continue reading →

Glioma Pipeline Expands as 180+ Pharma Companies Advance Several Novel Therapies, Finds DelveInsight | Aivita Biomedical, Denovo BioPharma, Medicenna Therapeutics, Eli Lilly, Candel Therapeutics

Glioma – Pipeline Insight, 2026 DelveInsight’s “Glioma – Pipeline Insight, 2026” report provides comprehensive insights about 180+ companies, including Aivita Biomedical, Inc., Denovo BioPharma, Medicenna Therapeutics, Inc., Eli Lilly and Company, Candel Therapeutics, Mustang Bio, AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, … Continue reading →